2024-04-012025-03-312025-03-31false08099238Evolutio Care Innovations Limited2025-04-30falseiso4217:GBPxbrli:pure080992382024-04-01080992382025-03-31080992382024-04-012025-03-31080992382023-04-01080992382024-03-31080992382023-04-012024-03-3108099238bus:SmallEntities2024-04-012025-03-3108099238bus:AuditExempt-NoAccountantsReport2024-04-012025-03-3108099238bus:FullAccounts2024-04-012025-03-3108099238bus:PrivateLimitedCompanyLtd2024-04-012025-03-3108099238core:WithinOneYear2025-03-3108099238core:AfterOneYear2025-03-3108099238core:WithinOneYear2024-03-3108099238core:AfterOneYear2024-03-3108099238core:ShareCapital2025-03-3108099238core:SharePremium2025-03-3108099238core:RevaluationReserve2025-03-3108099238core:OtherReservesSubtotal2025-03-3108099238core:RetainedEarningsAccumulatedLosses2025-03-3108099238core:ShareCapital2024-03-3108099238core:SharePremium2024-03-3108099238core:RevaluationReserve2024-03-3108099238core:OtherReservesSubtotal2024-03-3108099238core:RetainedEarningsAccumulatedLosses2024-03-3108099238core:LandBuildings2025-03-3108099238core:PlantMachinery2025-03-3108099238core:Vehicles2025-03-3108099238core:FurnitureFittings2025-03-3108099238core:OfficeEquipment2025-03-3108099238core:NetGoodwill2025-03-3108099238core:IntangibleAssetsOtherThanGoodwill2025-03-3108099238core:ListedExchangeTraded2025-03-3108099238core:UnlistedNon-exchangeTraded2025-03-3108099238core:LandBuildings2024-03-3108099238core:PlantMachinery2024-03-3108099238core:Vehicles2024-03-3108099238core:FurnitureFittings2024-03-3108099238core:OfficeEquipment2024-03-3108099238core:NetGoodwill2024-03-3108099238core:IntangibleAssetsOtherThanGoodwill2024-03-3108099238core:ListedExchangeTraded2024-03-3108099238core:UnlistedNon-exchangeTraded2024-03-3108099238core:LandBuildings2024-04-012025-03-3108099238core:PlantMachinery2024-04-012025-03-3108099238core:Vehicles2024-04-012025-03-3108099238core:FurnitureFittings2024-04-012025-03-3108099238core:OfficeEquipment2024-04-012025-03-3108099238core:NetGoodwill2024-04-012025-03-3108099238core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108099238core:ListedExchangeTraded2024-04-012025-03-3108099238core:UnlistedNon-exchangeTraded2024-04-012025-03-3108099238core:MoreThanFiveYears2024-04-012025-03-3108099238core:Non-currentFinancialInstruments2025-03-3108099238core:Non-currentFinancialInstruments2024-03-3108099238dpl:CostSales2024-04-012025-03-3108099238dpl:DistributionCosts2024-04-012025-03-3108099238core:LandBuildings2024-04-012025-03-3108099238core:PlantMachinery2024-04-012025-03-3108099238core:Vehicles2024-04-012025-03-3108099238core:FurnitureFittings2024-04-012025-03-3108099238core:OfficeEquipment2024-04-012025-03-3108099238dpl:AdministrativeExpenses2024-04-012025-03-3108099238core:NetGoodwill2024-04-012025-03-3108099238core:IntangibleAssetsOtherThanGoodwill2024-04-012025-03-3108099238dpl:GroupUndertakings2024-04-012025-03-3108099238dpl:ParticipatingInterests2024-04-012025-03-3108099238dpl:GroupUndertakingscore:ListedExchangeTraded2024-04-012025-03-3108099238core:ListedExchangeTraded2024-04-012025-03-3108099238dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-04-012025-03-3108099238core:UnlistedNon-exchangeTraded2024-04-012025-03-3108099238dpl:CostSales2023-04-012024-03-3108099238dpl:DistributionCosts2023-04-012024-03-3108099238core:LandBuildings2023-04-012024-03-3108099238core:PlantMachinery2023-04-012024-03-3108099238core:Vehicles2023-04-012024-03-3108099238core:FurnitureFittings2023-04-012024-03-3108099238core:OfficeEquipment2023-04-012024-03-3108099238dpl:AdministrativeExpenses2023-04-012024-03-3108099238core:NetGoodwill2023-04-012024-03-3108099238core:IntangibleAssetsOtherThanGoodwill2023-04-012024-03-3108099238dpl:GroupUndertakings2023-04-012024-03-3108099238dpl:ParticipatingInterests2023-04-012024-03-3108099238dpl:GroupUndertakingscore:ListedExchangeTraded2023-04-012024-03-3108099238core:ListedExchangeTraded2023-04-012024-03-3108099238dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-04-012024-03-3108099238core:UnlistedNon-exchangeTraded2023-04-012024-03-3108099238core:NetGoodwill2025-03-3108099238core:IntangibleAssetsOtherThanGoodwill2025-03-3108099238core:LandBuildings2025-03-3108099238core:PlantMachinery2025-03-3108099238core:Vehicles2025-03-3108099238core:FurnitureFittings2025-03-3108099238core:OfficeEquipment2025-03-3108099238core:AfterOneYear2025-03-3108099238core:WithinOneYear2025-03-3108099238core:ListedExchangeTraded2025-03-3108099238core:UnlistedNon-exchangeTraded2025-03-3108099238core:ShareCapital2025-03-3108099238core:SharePremium2025-03-3108099238core:RevaluationReserve2025-03-3108099238core:OtherReservesSubtotal2025-03-3108099238core:RetainedEarningsAccumulatedLosses2025-03-3108099238core:NetGoodwill2024-03-3108099238core:IntangibleAssetsOtherThanGoodwill2024-03-3108099238core:LandBuildings2024-03-3108099238core:PlantMachinery2024-03-3108099238core:Vehicles2024-03-3108099238core:FurnitureFittings2024-03-3108099238core:OfficeEquipment2024-03-3108099238core:AfterOneYear2024-03-3108099238core:WithinOneYear2024-03-3108099238core:ListedExchangeTraded2024-03-3108099238core:UnlistedNon-exchangeTraded2024-03-3108099238core:ShareCapital2024-03-3108099238core:SharePremium2024-03-3108099238core:RevaluationReserve2024-03-3108099238core:OtherReservesSubtotal2024-03-3108099238core:RetainedEarningsAccumulatedLosses2024-03-3108099238core:NetGoodwill2023-04-0108099238core:IntangibleAssetsOtherThanGoodwill2023-04-0108099238core:LandBuildings2023-04-0108099238core:PlantMachinery2023-04-0108099238core:Vehicles2023-04-0108099238core:FurnitureFittings2023-04-0108099238core:OfficeEquipment2023-04-0108099238core:AfterOneYear2023-04-0108099238core:WithinOneYear2023-04-0108099238core:ListedExchangeTraded2023-04-0108099238core:UnlistedNon-exchangeTraded2023-04-0108099238core:ShareCapital2023-04-0108099238core:SharePremium2023-04-0108099238core:RevaluationReserve2023-04-0108099238core:OtherReservesSubtotal2023-04-0108099238core:RetainedEarningsAccumulatedLosses2023-04-0108099238core:AfterOneYear2024-04-012025-03-3108099238core:WithinOneYear2024-04-012025-03-3108099238core:Non-currentFinancialInstrumentscore:CostValuation2024-04-012025-03-3108099238core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-012025-03-3108099238core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-012025-03-3108099238core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-012025-03-3108099238core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-012025-03-3108099238core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-012025-03-3108099238core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3108099238core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3108099238core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-012025-03-3108099238core:Non-currentFinancialInstrumentscore:CostValuation2025-03-3108099238core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-03-3108099238core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-03-3108099238core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-03-3108099238core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-03-3108099238core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-03-3108099238core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-03-3108099238core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-03-3108099238core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-03-3108099238core:Non-currentFinancialInstrumentscore:CostValuation2024-03-3108099238core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-03-3108099238core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-03-3108099238core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-03-3108099238core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-03-3108099238core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-03-3108099238core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-03-3108099238core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-03-3108099238core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-03-3108099238bus:Director12024-04-012025-03-3108099238bus:Director22024-04-012025-03-3108099238bus:Director32024-04-012025-03-3108099238bus:Director42024-04-012025-03-3108099238bus:Director52024-04-012025-03-3108099238bus:Director62024-04-012025-03-3108099238core:FurnitureFittingsToolsEquipment2024-03-3108099238core:FurnitureFittingsToolsEquipment2024-04-012025-03-3108099238core:FurnitureFittingsToolsEquipment2025-03-31080992381bus:Director32024-04-01080992381bus:Director32024-04-012025-03-31080992381bus:Director32025-03-31080992382024-04-01080992382024-04-012025-03-31080992382025-03-31

Evolutio Care Innovations Limited

Registered Number
08099238
(England and Wales)

Unaudited Financial Statements for the Year ended
31 March 2025

Evolutio Care Innovations Limited
Company Information
for the year from 1 April 2024 to 31 March 2025

Directors

Simon Hardman-Lea
Paul Heffernan
Peter Price-Taylor
Vishal Sharma
Melissa Sorenson
James Syrett

Registered Address

Fora Space Thames Tower
Station Road
Reading
RG1 1LX

Registered Number

08099238 (England and Wales)
Evolutio Care Innovations Limited
Balance Sheet as at
31 March 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Intangible assets3791,3331,021,678
Tangible assets4784,641504,258
1,575,9741,525,936
Current assets
Debtors51,056,189754,169
Cash at bank and on hand14,414223,085
1,070,603977,254
Creditors amounts falling due within one year6(1,712,003)(1,223,368)
Net current assets (liabilities)(641,400)(246,114)
Total assets less current liabilities934,5741,279,822
Creditors amounts falling due after one year7(569,878)(387,226)
Provisions for liabilities8(196,160)(95,809)
Net assets168,536796,787
Capital and reserves
Called up share capital151151
Share premium3,074,0023,074,002
Profit and loss account(2,905,617)(2,277,366)
Shareholders' funds168,536796,787
The financial statements were approved and authorised for issue by the Board of Directors on 30 April 2025, and are signed on its behalf by:
Peter Price-Taylor
Director
Registered Company No. 08099238
Evolutio Care Innovations Limited
Notes to the Financial Statements
for the year ended 31 March 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the financial reporting standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the rendering of services.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Operating leases
Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases are charged to the profit and loss account on a straight-line basis over the period of the lease.
Defined contribution pension plan
The company operates a defined contribution pension plan for the benefit of its employees. Contributions are recognised as expenses as they become payable. Differences between contributions payable in the year and those actually paid are recognised as either prepayments or accruals in the balance sheet. The assets of the defined contribution pension scheme are held separately from those of the company in an independently administered fund.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Current taxation
Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income. Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Intangible assets
Intangible assets are stated at cost less accumulated amortisation and accumulated impairment losses. The assets are reviewed for impairment if the above factors indicate that the carrying amount may be impaired. Amortisation is included in 'administrative expenses' in the profit and loss account.
Goodwill
Goodwill arising on an acquisition of a business is carried at cost less accumulated impairment losses, if any. Goodwill is amortised over its expected useful life which is estimated to be ten years. Goodwill is assessed for impairment when there are indicators of impairment and any impairment is charged to the income statement. No reversals of impairment are recognised.
Tangible fixed assets and depreciation
All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Straight line (years)
Plant and machinery4
Fixtures and fittings5
Office Equipment3
Finance leases and hire purchase contracts
Assets held under finance leases which are leases where substantially all the risks and rewards of ownership of the asset have passed to the company, and hire purchase contracts are capitalised in the balance sheet. They are depreciated over the shorter of their useful lives or the term of the lease.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash at bank and on hand, demand deposits with banks and other short-term highly liquid investments with original maturities of three months or less. Bank overdrafts are disclosed separately. For the purpose of the cash flow statement, bank overdrafts form an integral part of the company's cash management and are included as a component of cash and cash equivalents.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
2.Average number of employees

20252024
Average number of employees during the year11889
3.Intangible assets

Goodwill

Other

Total

£££
Cost or valuation
At 01 April 2446,3743,814,1503,860,524
Additions-146,667146,667
At 31 March 2546,3743,960,8174,007,191
Amortisation and impairment
At 01 April 2440,5122,798,3342,838,846
Charge for year2,037374,975377,012
At 31 March 2542,5493,173,3093,215,858
Net book value
At 31 March 253,825787,508791,333
At 31 March 245,8621,015,8161,021,678
4.Tangible fixed assets

Land & buildings

Plant & machinery

Fixtures & fittings

Office Equipment

Total

£££££
Cost or valuation
At 01 April 24322,5171,130,135139,378305,5051,897,535
Additions-387,757100,125121,061608,943
At 31 March 25322,5171,517,892239,503426,5662,506,478
Depreciation and impairment
At 01 April 24271,023817,69358,014246,5471,393,277
Charge for year39,507212,44531,97044,638328,560
At 31 March 25310,5301,030,13889,984291,1851,721,837
Net book value
At 31 March 2511,987487,754149,519135,381784,641
At 31 March 2451,494312,44281,36458,958504,258
5.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables897,520696,506
Other debtors126,02436,291
Prepayments and accrued income32,64521,372
Total1,056,189754,169
6.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables696,235388,437
Bank borrowings and overdrafts185,125156,709
Taxation and social security301,926228,482
Finance lease and HP contracts234,387191,248
Other creditors277,015235,498
Accrued liabilities and deferred income17,31522,994
Total1,712,0031,223,368
7.Creditors: amounts due after one year

2025

2024

££
Bank borrowings and overdrafts348,265262,357
Other creditors221,613124,869
Total569,878387,226
8.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)196,16095,809
Total196,16095,809
9.Operating lease commitments
At 31 March 2025, the company had total commitments under non-cancellable operating leases over the remaining life of those leases of £1,665,614.
10.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
Peter Price-Taylor19,004118,88065,61272,272
19,004118,88065,61272,272
The advance to the director was repaid in cash within nine months of the financial year end. The advance was repayable upon demand and interest was charged at HMRC interest rates.